Exit Text Mode

Macular Disease Foundation Australia logo

    MDFA News

    Answering your questions about eye health and macular disease

    Our eye health video series answers some of the frequently asked questions about macular disease.

    Watch the videos

    Most recent

    Image of older guy holding a pair of glasses and looking thoughtfully at the camera

    CATT study raises questions

    We reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.

    Two men chatting about a book

    Eyes on the future

    The 2011 Eyes on the Future report provides the most comprehensive compilation of macular degeneration statistics and research ever undertaken in Australia.

    Image of an Asian mother and daughter

    Hyperbaric oxygen treatment

    There is no compelling evidence-based research that hyperbaric oxygen treatment has a beneficial effect on AMD.

    Launch of Research Grants program

    The Macular Degeneration Foundation has established a Research Grants Program to raise $10 million over the next 10 years.

    Image of a senior man reading a book with a magnifier

    Low vision aids subsidy needed

    The Macular Degeneration Foundation is advocating for national subsidy scheme for low vision aids and technology for people with low vision.

    Annastacia’s story

    Annastacia Palaszczuk was diagnosed with the wet form of macular degeneration when she was just 34 years of age.

    Image showing two men with the one putting his hand on the others shoulder

    Awareness week 2010

    The Hon Annastacia Palaszczuk, Queensland Minister for Disability and Multicultural Affairs launched MD Awareness Week with her personal story of MD.

    Image of a man smliing at the camera

    Know the symptoms

    Survey shows risk of over 50s dismissing macular degeneration symptoms.

    Medicare benefits for Avastin

    Patients with wet macular degeneration (MD) who are receiving Avastin injections will again be entitled to a Medicare Rebate.